Agree JWNice to see CEO holding firm/slightly up, while broader commodities stocks all being sold off / shorted - likely response due to A$ appreciationRL22
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%